Genetic Diversity Study in Pakistan

Summary of Findings from the Human Genetic Study in Pakistan

Study Overview:

• Conducted in Pakistan, the study identified so-called ‘human knockouts’, where both copies of a gene have inactive variants in participants.
• Sample Size: 173,303 individuals, approximately 20% exhibited loss-of-function variants in at least one gene.
• Total identified human knockouts: 6,476 genes (about one-third of protein-coding genes).

Genetics Background:

• Human genome comprises 23 pairs of chromosomes, containing DNA sequences made of four bases (A, T, G, C).
• Genes serve as instructions for protein synthesis, resulting in diverse functions in the body from digestion to immune defense.
• Loss-of-function mutations can lead to different health outcomes ranging from benign to harmful effects.

Cultural Context:

• High prevalence of consanguineous marriages in Pakistan, with almost two-thirds of marriages being between relatives. This raises the likelihood of inheriting rare gene variants.

Study Significance:

• Allows for direct research on the consequences of genetic variations in human individuals, invaluable for understanding disease mechanisms.
• Example of beneficial findings includes the APOC3 gene, associated with triglyceride regulation, providing a basis for clinical drugs like olezarsen for metabolic disorders.

Previous Research:

• A 2017 study identified significant associations between genetic variants and various biochemical traits among Pakistani adults; findings utilized ‘recall by genotype’ to facilitate further research on specific genetic cases.

Pakistan Genome Resource (June 2026):

• An extensive genomic catalog linked genetic data from 173,303 participants to medical records, uncovering 6.6 million variants, 47% of which were unique.
• Specific genetic observations include:
  • Loss of CIDEB gene linked to reduced liver enzyme levels.
  • LRRK2 gene loss raises concerns regarding kidney function and implications for Parkinson's treatment.

Implications for Drug Development:

• Genetic data assists in identifying viable targets for drug therapy and avoiding ineffective ones.
• Highlights the distinction between lifelong gene loss and drug-induced gene inhibition, emphasizing the need for careful drug design.

Ethical Considerations:

• Ethical implications surrounding consanguinity in populations: increased risk of recessive disorders necessitates informed consent and genetic counseling.
• The importance of fair sharing of research benefits for participants is emphasized.

Comparative Perspective: India’s Genetics Initiative:

• India's GenomeIndia aims to catalog genetic diversity across 83 population groups, facilitating population-specific genomic research, albeit with different underlying genetic structures.

Conclusion:

• The study illustrates the potential of human genetic diversity in informing medical science, drug development, and understanding of genetic disorders. Emphasizes a shift to direct observation of natural gene knockouts to inform clinical practice, stressing the importance of ethical research practices in genetics.